IMMUNOSYS LTD

Company number 07939385 · Active · Sittingbourne ME9 8EF

D
Firmoscan score 35/100

IMMUNOSYS LTD is an active private limited company (company number 07939385) incorporated on 7 February 2012, registered in Sittingbourne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 28 February 2025, showing net assets of −£68k and cash of £116, with 0 employees on average. Net assets fell 2% on the prior period (−£67k).

By net assets it sits in the bottom quarter of 59 comparable companies in Kent (median £2,535, upper quartile £84k).

Key dates

Incorporated
7 February 2012
Next accounts due
28 November 2026 — in 39 days
Confirmation statement due
21 February 2027 — in 124 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110
Research and experimental development on biotechnology
SIC 72200
Research and experimental development on social sciences and humanities
Accounts type
Total Exemption Full
Size band
Micro (Companies Act thresholds)

Financials — 2 periods on record, latest ending 28 February 2025

Net assets
Net assetsFeb 2024: −£67k; Feb 2025: −£68k−£67k−£68kFeb 2024Feb 2025
Cash at bank
Cash at bankFeb 2024: £117; Feb 2025: £116£117£116Feb 2024Feb 2025
Average employees
Average employeesFeb 2024: 0; Feb 2025: 000Feb 2024Feb 2025
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
28 February 2025−£68k£116—£210——0
29 February 2024−£67k£117—£420——0
Current ratio
0.55 — current liabilities exceed current assets

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Firmoscan score: 35/100 (grade D)

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.

Ownership and control

  • Dr Masih Alam — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 6 April 2016
  • Dr Rawshan Reza Choudhury — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 6 April 2016

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

Similar companies in Kent

Same activity (research and experimental development on biotechnology), closest in incorporation date.

Reminders for IMMUNOSYS LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.